QUOTE AND NEWS
FiercePharma  Dec 19  Comment 
Novo Nordisk has a while yet to wait for another shot at FDA approval for Tresiba, a drug on which it has pinned its future, but it continues win support for it in Europe.
GenEng News  Dec 18  Comment 
Xencor signed a collaboration and licensing agreement with Novo Nordisk to jointly discover biologic drug candidates for an undisclosed target by combining multiple Xencor XmAb® technologies, including bispecific and immune inhibitor...
Wall Street Journal  Dec 16  Comment 
Portuguese lender Banco BPI said that it will participate in the first round of the bidding process for Novo Banco SA.
TheStreet.com  Dec 15  Comment 
The European Commission is standing by its approval last summer of Portugal's €4.9 billion ($6.1 billion) rescue and subsequent breakup of Banco Espirito Santo SA as a legal challenge from Daniel Loeb's Third Point LLC and other miffed...
Financial Times  Dec 4  Comment 
Bank created from Espírito Santo reports capital strength measure of 9.2%
Wall Street Journal  Nov 26  Comment 
Novo has managed to damp fears of a price war in insulin. But worries about mounting competition could make the Danish diabetes specialist more geared to the success or failure of its pipeline drugs.
FiercePharma  Nov 25  Comment 
Novo Nordisk says it has reorganized its executive team, with EVP Lise Kingo making an exit and her duties divvied up among the company's remaining top execs.
Financial Times  Nov 19  Comment 
Novo Banco created in August out of a €4.9bn bailout is the biggest item on the sales list





You may also be interested in articles related to Novo Nordisk A/S (NVO):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki